Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2008
12/03/2008CN100438905C Stable liquid formulations of botulinum toxin
12/03/2008CN100438864C Eye medicine for treating fungal keratitis
12/03/2008CN100438862C Composition for administration to mucosa and containing coenzyme Q as active ingredient
12/03/2008CN100438860C (f)-cycloolivil as antioxidant obtained from stereospermum personatum
12/02/2008US7459540 Fibroblast growth factor-like polypeptides
12/02/2008US7459470 For example, N-(Isoquinolin-3-yl)-2-(4-pyridylmethyl)aminobenzoic acid amide-N-oxide; use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, such as psoriasis, arthritis, hemangioma, angiofibroma, eye diseases, cirrhosis of the liver
12/02/2008US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism
12/02/2008US7459455 Pyrimidine compounds
12/02/2008US7459441 Remedies for dry eye and diseases associated with dry eye
12/02/2008US7459440 Ocular tear growth factor-like protein
12/02/2008US7459171 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area of penetrants; drug delivery
12/02/2008CA2361841C Mevinolin derivatives
12/02/2008CA2346631C Antibacterial aqueous ophthalmic formulations containing ofloxacin and use of chitosan for solubilizing ofloxacin suspended in an aqueous media
12/02/2008CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
12/02/2008CA2306371C Use of flunarizine for the topical treatment of glaucoma
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
11/2008
11/27/2008WO2008144623A1 Cyclic lactams for the treatment of glaucoma or elevated intraocular pressure
11/27/2008WO2008144399A1 COMPLEXES COMPRISING α2-ADRENERGIC RECEPTOR AGONISTS AND COMPOSITIONS
11/27/2008WO2008144347A1 Combinations comprising a fluoroquinolone for treating, reducing, ameliorating, or preventing infections
11/27/2008WO2008143254A1 Pharmaceutical containing pparδ agonist
11/27/2008WO2008096804A8 Eye drop preparation comprising latanoprost
11/27/2008WO2008080037A3 Carotenoids of enhanced bioavailability
11/27/2008US20080293791 Valsartan salts
11/27/2008US20080293748 Thioxanthine Derivatives as Myeloperoxidase Inhibitors
11/27/2008US20080293721 Arylthioacetamide carboxylate derivatives as fkbp inhibitors for the treatment of neurological diseases
11/27/2008US20080292726 Ophthalmic gallium compositions and methods of their use
11/27/2008US20080292680 Hypercompressed polymer particles for controlled release ophthalmic medications
11/27/2008US20080292662 Vaccine Comprising Recombinant Clpp Protein of Streptococcus Pneumoniae
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008CA2687957A1 Pharmaceutical containing ppar.delta. agonist
11/27/2008CA2686720A1 Drug delivery system with scleral lens
11/26/2008EP1995243A1 Triazole derivative or salt thereof
11/26/2008EP1994933A1 Aqueous composition
11/26/2008EP1994932A1 Use of N-desmethylclozapine to treat human psychosis
11/26/2008EP1994931A1 Prophylactic or therapeutic agent for allergic ophthalmic disease or allergic nasal disease comprising tricyclic triazolobenzoazepine derivative
11/26/2008EP1994929A1 Use of derivatives of naphthalenesulphonic or quinolinesulphonic acid in the treatment of vasoproliferative ocular diseases
11/26/2008EP1993673A2 Injectable combination therapy for eye disorders
11/26/2008EP1993619A2 Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives
11/26/2008EP1993584A2 Compositions and methods for the treatment of ophthalmic disease
11/26/2008EP1993578A1 Substance for the treatment of tinnitus
11/26/2008EP1993530A2 Use of dha and ara in the preparation of a composition for regulating gene expression
11/26/2008EP1993525A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain
11/26/2008EP1993383A2 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation
11/26/2008EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/26/2008EP1381382B1 Methods and compositions for the treatment of diseases of the eye
11/26/2008EP1330452B1 Pyrazine derivatives as modulators of tyrosine kinases
11/26/2008EP1234574B1 Hair growth stimulant
11/26/2008CN101312962A Therapeutic agent for cornea/conjunctive disorder
11/26/2008CN101310771A Visual function disorder improving agents
11/26/2008CN100436439C Dimeric isoflavones
11/25/2008US7456253 Growth hormone releasing peptides
11/25/2008US7456158 4-dedimethylaminotetracycline derivatives
11/25/2008US7455986 Heparinase III and methods of specifically cleaving therewith
11/25/2008US7455855 Obtained by reacting polyalkylene glycol or a reactive derivative, a phospholipid and a drug with each other to form covalent bonds to form a delivery substance
11/25/2008US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule
11/25/2008CA2433032C Sustained release drug delivery devices with coated drug cores
11/25/2008CA2224369C Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use
11/20/2008WO2008140052A1 Prophylactic or therapeutic agent for posterior ocular disease comprising ropinirole or salt thereof as active ingredient
11/20/2008WO2008140051A1 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
11/20/2008WO2008139845A1 Novel amide derivative
11/20/2008WO2008139574A1 Crystalline form of lactam compound and process for producing the same
11/20/2008WO2008138350A1 Prevention of intraocular fibrosis
11/20/2008WO2008101052A8 Compositions and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract
11/20/2008WO2008094912B1 Substituted gamma lactams as therapeutic agents
11/20/2008WO2008006052A3 Bicyclic heteroaryl inhibitors of pde4
11/20/2008US20080287528 Therapeutic methods and compositions involving isoflavones
11/20/2008US20080287501 Therapeutic uses of an insulin secretion enhancer
11/20/2008US20080287498 Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/20/2008US20080287489 Ophthalmic compositions for treating ocular hypertension
11/20/2008US20080287477 Novel Compounds as Modulators of Ppar
11/20/2008US20080287385 Inhibitor oligonucleotides and their use for specific repression of a gene
11/20/2008US20080287381 Injectable Agent for the Targeted Treatment of Retinal Ganglion Cells
11/20/2008US20080287341 Treatment of vascular abnormalities using nanoparticles
11/20/2008US20080286378 Administering via eye drops
11/20/2008US20080286338 Drug delivery system with scleral lens
11/20/2008US20080286337 Method of treating a disease in an eye using a scleral lens
11/20/2008US20080286334 Poly lactic co-glycolic acid copolymer biodegradable polymer matrix; eye implant infused with ace-inhibitors, endogenous cytokines, agents that influence basement membrane, agents that influence the growth of endothelial cells, adrenergic agonists or blockers; uveitis, macular edema, macular degeneration
11/20/2008US20080286303 Mutant Hin47 protein with decreased protease activity, and a high molecular weight protein of a strain of non-typeable Haemophilus influenzae; may be combined with diphtheria or tetanus toxoids, pertussis antigens or non-virulent poliovirus; immunization; otitis media
11/20/2008US20080286288 Vascular endothelial growth factor 2
11/20/2008US20080286255 Treatment for eye disorder
11/20/2008US20080286250 Implantable Biocompatible Immunoisolatory Vehicle for Delivery of Gdnf
11/20/2008US20080286211 Treating pain associated with epithelial lesions and disorders of impaired mucin function using a pharmaceutical composition containing mucin glycoproteins in combination with therapeutic agents, e.g., trefoil polypeptides
11/20/2008CA2686394A1 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
11/19/2008EP1992644A1 Antibodies against CCR4 and its fragments
11/19/2008EP1992633A1 VEGI, an inhibitor of angiogenesis and tumor growth
11/19/2008EP1992340A1 Improved ophthalmic and contact lens solution
11/19/2008EP1992317A2 Devices for intraocular drug delivery
11/19/2008EP1991249A2 Treatment with cyclosporin a
11/19/2008EP1991218A1 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives
11/19/2008EP1991205A1 Ocular therapy using sirtuin-activating agents
11/19/2008EP1680413B1 NEW RAR-beta RECEPTOR-ACTIVATING LIGAND, METHOD FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS
11/19/2008EP1470107B1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists
11/19/2008EP1453539B1 Immunotherapeutic methods and systems
11/19/2008EP1343529B1 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
11/19/2008CN101309923A N-sulfamoyl-N -benzopyranpiperidines as inhibitors of carbonic anhydrases
11/19/2008CN101309667A Medical composite treating disease of inner ear
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/19/2008CN101306144A Decoction for treating otitis media suppurativa acuta
11/19/2008CN101306143A Ear drops for treating otitis media suppurativa acuta